Literature DB >> 22527638

Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro.

Suresh Govindan1, Jason Sarkey, Xiang Ji, Nagalingam R Sundaresan, Mahesh P Gupta, Pieter P de Tombe, Sakthivel Sadayappan.   

Abstract

Cardiac myosin binding protein-C (cMyBP-C) plays a role in sarcomeric structure and stability, as well as modulating heart muscle contraction. The 150 kDa full-length (FL) cMyBP-C has been shown to undergo proteolytic cleavage during ischemia-reperfusion injury, producing an N-terminal 40 kDa fragment (mass 29 kDa) that is predominantly associated with post-ischemic contractile dysfunction. Thus far, the pathogenic properties of such truncated cMyBP-C proteins have not been elucidated. In the present study, we hypothesized that the presence of these 40 kDa fragments is toxic to cardiomyocytes, compared to the 110 kDa C-terminal fragment and FL cMyBP-C. To test this hypothesis, we infected neonatal rat ventricular cardiomyocytes and adult rabbit ventricular cardiomyocytes with adenoviruses expressing the FL, 110 and 40 kDa fragments of cMyBP-C, and measured cytotoxicity, Ca(2+) transients, contractility, and protein-protein interactions. Here we show that expression of 40 kDa fragments in neonatal rat ventricular cardiomyocytes significantly increases LDH release and caspase 3 activity, significantly reduces cell viability, and impairs Ca(2+) handling. Adult cardiomyocytes expressing 40 kDa fragments exhibited similar impairment of Ca(2+) handling along with a significant reduction of sarcomere length shortening, relaxation velocity, and contraction velocity. Pull-down assays using recombinant proteins showed that the 40 kDa fragment binds significantly to sarcomeric actin, comparable to C0-C2 domains. In addition, we discovered several acetylation sites within the 40 kDa fragment that could potentially affect actomyosin function. Altogether, our data demonstrate that the 40 kDa cleavage fragments of cMyBP-C are toxic to cardiomyocytes and significantly impair contractility and Ca(2+) handling via inhibition of actomyosin function. By elucidating the deleterious effects of endogenously expressed cMyBP-C N-terminal fragments on sarcomere function, these data contribute to the understanding of contractile dysfunction following myocardial injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527638      PMCID: PMC3368277          DOI: 10.1007/s10974-012-9292-y

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  40 in total

Review 1.  Cardiac myosin binding protein C.

Authors:  S Winegrad
Journal:  Circ Res       Date:  1999-05-28       Impact factor: 17.367

2.  Structural evidence for the interaction of C-protein (MyBP-C) with actin and sequence identification of a possible actin-binding domain.

Authors:  John M Squire; Pradeep K Luther; Carlo Knupp
Journal:  J Mol Biol       Date:  2003-08-15       Impact factor: 5.469

3.  Myosin binding protein C interaction with actin: characterization and mapping of the binding site.

Authors:  Inna N Rybakova; Marion L Greaser; Richard L Moss
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

4.  Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice.

Authors:  Samantha P Harris; Christopher R Bartley; Timothy A Hacker; Kerry S McDonald; Pamela S Douglas; Marion L Greaser; Patricia A Powers; Richard L Moss
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

5.  Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice.

Authors:  B K McConnell; K A Jones; D Fatkin; L H Arroyo; R T Lee; O Aristizabal; D H Turnbull; D Georgakopoulos; D Kass; M Bond; H Niimura; F J Schoen; D Conner; D A Fischman; C E Seidman; J G Seidman; D H Fischman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

6.  Cardiac myosin binding protein-C: a potential early-stage, cardiac-specific biomarker of ischemia-reperfusion injury.

Authors:  Sakthivel Sadayappan
Journal:  Biomark Med       Date:  2012-02       Impact factor: 2.851

7.  Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle.

Authors:  O'Neal Copeland; Sakthivel Sadayappan; Andrew E Messer; Ger J M Steinen; Jolanda van der Velden; Steven B Marston
Journal:  J Mol Cell Cardiol       Date:  2010-09-17       Impact factor: 5.000

8.  Unique single molecule binding of cardiac myosin binding protein-C to actin and phosphorylation-dependent inhibition of actomyosin motility requires 17 amino acids of the motif domain.

Authors:  Abbey Weith; Sakthivel Sadayappan; James Gulick; Michael J Previs; Peter Vanburen; Jeffrey Robbins; David M Warshaw
Journal:  J Mol Cell Cardiol       Date:  2011-09-25       Impact factor: 5.000

9.  Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.

Authors:  Björn C Knollmann; Paulus Kirchhof; Syevda G Sirenko; Hubertus Degen; Anne E Greene; Tilmann Schober; Jessica C Mackow; Larissa Fabritz; James D Potter; Martin Morad
Journal:  Circ Res       Date:  2003-02-06       Impact factor: 17.367

10.  Independent FHC-related cardiac troponin T mutations exhibit specific alterations in myocellular contractility and calcium kinetics.

Authors:  Todd E Haim; Candice Dowell; Theodhor Diamanti; James Scheuer; Jil C Tardiff
Journal:  J Mol Cell Cardiol       Date:  2007-03-31       Impact factor: 5.000

View more
  24 in total

1.  Introducing a series of topical special issues of the Journal of Muscle Research and Cell Motility: MYBPC3 special issue editorial.

Authors:  Steven B Marston; Mathias Gautel
Journal:  J Muscle Res Cell Motil       Date:  2012-05       Impact factor: 2.698

2.  Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction.

Authors:  Suresh Govindan; Diederik Wd Kuster; Brian Lin; Daniel J Kahn; Walter P Jeske; Jeanine M Walenga; Fred Leya; Debra Hoppensteadt; Jawed Fareed; Sakthivel Sadayappan
Journal:  Am J Cardiovasc Dis       Date:  2013-06-10

3.  A gain-of-function mutation in the M-domain of cardiac myosin-binding protein-C increases binding to actin.

Authors:  Kristina L Bezold; Justin F Shaffer; Jaskiran K Khosa; Elaine R Hoye; Samantha P Harris
Journal:  J Biol Chem       Date:  2013-06-19       Impact factor: 5.157

4.  A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.

Authors:  Diederik W D Kuster; Suresh Govindan; Tzvia I Springer; Jody L Martin; Natosha L Finley; Sakthivel Sadayappan
Journal:  J Biol Chem       Date:  2015-01-12       Impact factor: 5.157

5.  Release kinetics of circulating cardiac myosin binding protein-C following cardiac injury.

Authors:  Diederik W D Kuster; Adriana Cardenas-Ospina; Lawson Miller; Christoph Liebetrau; Christian Troidl; Holger M Nef; Helge Möllmann; Christian W Hamm; Karen S Pieper; Kenneth W Mahaffey; Neal S Kleiman; Bruno D Stuyvers; Ali J Marian; Sakthivel Sadayappan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-13       Impact factor: 4.733

Review 6.  MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25 bp deletion mutation.

Authors:  Diederik W D Kuster; Sakthivel Sadayappan
Journal:  Pflugers Arch       Date:  2013-12-11       Impact factor: 3.657

7.  Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy.

Authors:  David Barefield; Mohit Kumar; Pieter P de Tombe; Sakthivel Sadayappan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

8.  Characterization of the cardiac myosin binding protein-C phosphoproteome in healthy and failing human hearts.

Authors:  Viola Kooij; Ronald J Holewinski; Anne M Murphy; Jennifer E Van Eyk
Journal:  J Mol Cell Cardiol       Date:  2013-04-22       Impact factor: 5.000

9.  Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.

Authors:  Harold H Bach; Yee M Wong; Abhishek Tripathi; Amanda M Nevins; Richard L Gamelli; Brian F Volkman; Kenneth L Byron; Matthias Majetschak
Journal:  Mol Med       Date:  2014-10-13       Impact factor: 6.354

10.  N-terminal fragment of cardiac myosin binding protein-C triggers pro-inflammatory responses in vitro.

Authors:  Christoph Lipps; Jenine H Nguyen; Lukas Pyttel; Thomas L Lynch; Christoph Liebetrau; Ganna Aleshcheva; Sandra Voss; Oliver Dörr; Holger M Nef; Helge Möllmann; Christian W Hamm; Sakthivel Sadayappan; Christian Troidl
Journal:  J Mol Cell Cardiol       Date:  2016-09-08       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.